Long-term outcomes of the Corona crisis

COVID-19 care and research at the UMCG Research
COVID-19 has had a tremendous impact on all our lives. We are gaining a lot of information about the development of the disease and short-term effect, but we do not know the long-term outcomes of this pandemic. Our COVID-19 projects will contribute to the understanding of the impact of the COVID-19 pandemic, not only on health but also on society and on the healthcare system.

The University Medical Center in Groningen (UMCG) is not only a hospital that treats COVID-19 patients, it is also a research institute where our investigators are currently busy studying the virus, the development of the disease and the effect of the current crisis on physical and mental health.

Timeline

  1. Home all news Influence of DNA on behaviour and wellbeing during coronavirus pandemic has increased

    Posted

    June 6, 2021

    Because Dutch people became more self-reliant during the coronavirus pandemic, the extent to which DNA influences their behaviour and wellbeing has become greater. This is the conclusion of a study of 30,000 participants of the Lifelines coronavirus study conducted by the University of Groningen (UG) and the University Medical Center Groningen (UMCG).

    Read the full news article

  2. One in ten young children did not play with friends during the coronavirus pandemic

    Posted

    During the period that primary schools were closed, 11% of young children did not play with children from outside their own family. In addition, one in three parents did not understand all of the teaching material for children in the top class. These findings come from the Lifelines Corona study carried out by the University of Groningen (UG) and the University Medical Center Groningen (UMCG). The study provides insight into how over 2,000 families with children of primary school age managed home schooling while the schools were closed.

    Read the news article

  3. Yingying Cong awarded ISBA Fellowship by developing an anti-coronavirus compound

    Posted

    The ISBA Fellowship has awarded Yingying Cong, postdoctoral researcher in the laboratory of Prof. Fulvio Reggiori at the Department of Biomedical Sciences of Cells and Systems of the UMCG, a ISBA Fellowship worth € 30.000. With the grant she will be able to develop a pan-anti-coronavirus compounds that specifically target the complex we found.

    Read the news article

  4. Patients on the waiting list for surgery benefit from COVID-19 vaccination

    Posted

    March 31, 2021

    Patients on the waiting list for elective surgery benefit from a COVID-19 vaccination prior to their operation. Globally, thousands of postoperative deaths due to the virus may be prevented.

    These conclusions were drawn based on the data from a global study among more than 140,000 surgical patients. Schelto Kruijff, surgical oncologist at the UMCG and Jean-Paul de Vries, vascular surgeon and chair of the department of surgery at the UMCG, coordinated the Dutch contribution to this study. The results were published in the scientific journal British Journal of Surgery.

    Read the news article

  5. Study with Lifelines data into the transmission of the coronavirus within households

    Posted

    March 25, 2021
    How is it possible in many cases that when someone contracts the coronavirus, their family members do not become infected? The RIVM (National Institute for Public Health and the Environment), the University of Groningen and the University Medical Center Groningen (UMCG) will use data from the Lifelines coronavirus study to research how the transmission of the coronavirus within families works. To this end, the antibodies in the blood of 500 families in the Northern Netherlands will be studied.

    Read the news article

  6. UMCG to study potential coronavirus vaccine

    Posted

    The UMCG is going to study a potential COVID-19 vaccine: the AKS-452 vaccine produced by Akston Biosciences in the United States. The goal of the study is to research the safety and tolerability of and the reaction of the immune system to the vaccine. For the study, the UMCG is looking for 176 healthy volunteers aged between 18 and 65 who are willing to be vaccinated with the potential vaccine.  

    Read the news article

  7. Patients who test positive for COVID-19 should postpone operations to reduce the risk of mortality

    Posted

    A very significant number of international studies indicate that if possible, operations planned for patients who test positive for COVID-19 should be postponed for seven weeks.

    These patients appear to be two-and-a-half times more likely to die after an operation if the procedure takes place within the first six weeks of having tested positive. Over 140,000 patients in almost 1,700 hospitals worldwide took part in this study, including seventeen hospitals in the Netherlands. Schelto Kruijff and Jean Paul de Vries, surgical oncologist and vascular surgeon/head of the surgical department at the University Medical Center Groningen (UMCG) respectively, are coordinating the Dutch part of the study. The results have been published in the journal Anaesthesia.

    Read the news article

  8. Massive single-cell study suggests biological roots of COVID-19 risk factors

    Posted

    Human Cell Atlas researchers found cells vulnerable to viral infection in a wide range of tissues in the body.

    Read the news article

  9. Study into the effect of COVID-19 vaccines in vulnerable groups

    Posted


    UMCG researchers to study the effect of COVID-19 vaccines on kidney, lung transplant and cancer patients. For this, they will be granted approx. 7.2 million Euro from ZonMw.

    Read the news article

  10. Key nose cells identified as likely COVID-19 virus entry points

    Posted

    May 27, 2020
    ​Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells. The identification of these cells by among others Martijn Nawijn and Maarten van den Berge from GRIAC at University Medical Centre Groningen, researchers from the Wellcome Sanger Institute, University Cote d’Azur and CNRS, Nice and their collaborators, as part of the Human Cell Atlas Lung Biological Network, could help explain the high transmission rate of COVID-19.

    Read the news article